Clinical Trial Update: Immunotherapy for Advanced Liver Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 immunotherapy trial for hepatocellular carcinoma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Mirror Biologics, Inc. | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: SUSPENDED